🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

ABIVAX Société Anonyme

ABVX Healthcare
$106.66 $-6.92 (-6.09%)
Market Cap: $9.44 B
Gurus Holding
5
Popularity Rank
#1648
% of Shares Held
0.36%
Net Activity (Q2 2026)
-$62.27 M

Guru Ownership Trend

Guru Analysis for ABIVAX Société Anonyme (ABVX)

ABIVAX Société Anonyme (ABVX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $30.1 M.

Top institutional holders include Paul Tudor Jones and Chuck Royce.

Institutional sentiment is currently Bearish. This is evidenced by a $62.27 M net outflow during the quarter.

Recent activity highlights Chuck Royce who opened a new position. Conversely, Steven Cohen reduced exposure by 99.2%.

Key Holders

Top 5 by Value

$24.96 M
$6.01 M
$5.33 M
$670,031
$635,783

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$22.76 M
Total Buy Value
New Buys 2
Additions 1
-$85.03 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
3

FAQs for ABIVAX Société Anonyme (ABVX)

Major holders include Paul Tudor Jones ($24.96 M), Chuck Royce ($6.01 M), Lee Ainslie ($5.33 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 282,237 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $62.27 M, with 3 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ABVX. The total reported sell value was $85.03 M.

Yes, 2 managers opened new positions in ABVX, and 1 increased their existing holdings. The total reported buy value was $22.76 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% Add 84.4% 187,335 $24.96 M Q2 2026
0.05% New Buy 45,103 $6.01 M Q2 2026
0.05% New Buy 40,000 $5.33 M Q2 2026
0.00% Reduce -99.2% 5,028 $670,031 Q2 2026
0.00% Reduce -53.0% 4,771 $635,783 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form